Stay updated on FRα Clinical Trial: Mirvetuximab vs. Chemo
Sign up to get notified when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.

Latest updates to the FRα Clinical Trial: Mirvetuximab vs. Chemo page
- ChecktodayChange DetectedEnrollment status was updated to show recruitment is closed, which changes how the study is interpreted by potential participants and researchers. The page also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and makes minor labeling and revision-tag updates, reflecting a broader UI/content refresh.SummaryDifference0.2%

- Check8 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a version update in the site metadata.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.5.4 has been added and Revision: v3.5.3 removed. This reflects a minor update to the page’s documents without changing its core content.SummaryDifference0.0%

- Check36 days agoChange DetectedNo additions or deletions are listed in the provided change data. As a result, there is no text-level modification to evaluate for this page.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a release/version increment rather than substantive study information.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible study content changes are indicated.SummaryDifference0.0%

Stay in the know with updates to FRα Clinical Trial: Mirvetuximab vs. Chemo
Enter your email address, and we'll notify you when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.